July 30, 2026 08:50 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
'I received threats to join BJP': CJP founder Abhijeet Dipke's explosive allegation sparks fresh political row | Assam floods turn deadlier: 78 killed, more than 3 lakh remain affected | Supreme Court orders Delhi govt to treat protesters injured by pellet guns during NEET march | Bengal: Birbhum cash haul soars to ₹28.5 crore, 15 kg gold seized; stone trader’s manager arrested | Blue out, saffron in: Hockey India breaks silence after jersey row erupts | Ajinkya Rahane retires from international cricket: 'Melbourne hero' reveals what's next after Team India | 'I may look like young Hrithik Roshan': CJP's Saurav Das takes hilarious dig at Kangana Ranaut | Farmers storm Bhopal! Traffic crippled as protest over MSP intensifies | Supreme Court gives clean chit to Manmohan Singh in coal block scam case two years after death, accepts CBI closure report | Rahul Gandhi's 'student, idiot, andhbhakt' remark sparks uproar in Lok Sabha during anti-paper leak bill debate
Narendra Modi
Narendra Modi Twitter page

Narendra Modi to interact with Gennova Biopharma, Biological E and Dr. Reddy’s teams

| @indiablooms | Nov 30, 2020, at 01:41 am

New Delhi: Prime Minister Narendra Modi will interact via video conferencing with Gennova Biopharma, Biological E and Dr. Reddy’s teams involved in developing a COVID-19 vaccine on Monday.

In a tweet, the Prime Minister said, "Tomorrow, on 30th November 2020, PM @narendramodi will interact, via video conferencing, with three teams that are involved in developing a COVID-19 vaccine. The teams he will interact with are from Gennova Biopharma, Biological E and Dr. Reddy’s."

Meanwhile, the Serum Institute will apply within two weeks for an emergency license to use the coronavirus vaccine being developed by the University of Oxford and pharma giant AstraZeneca, the Indian vaccine maker's chief Adar Poonawalla said on Saturday after a meeting with Prime Minister Narendra Modi.

"As of now, we don't have anything in writing with the government of India on how many doses they will purchase but the indication is that it would be 300-400 million doses by July 2021," he told reporters at a press conference.

"We are in the process of applying in the next two weeks for the emergency use," he added.

PM Modi on Saturday visited Zydus Biotech Park in Ahmedabad and Bharat Biotech facility in Hyderabad to know more about the indigenous DNA based vaccine being developed by Zydus Cadila as well as the vaccine candidate by Bharat Biotech.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.